Related Experiment Video
Updated: Apr 25, 2026

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
Published on: May 26, 2023
Management of anticoagulation and hemostasis for pediatric extracorporeal membrane oxygenation
Arun Saini1, Philip C Spinella1
1Division of Critical Care Medicine, Department of Pediatrics, Washington School of Medicine in St Louis, 8th floor, Northwest Towers, One Children's Place, St Louis, MO 63110, USA.
Compared to in situ vascular physiology where pro and anti-hemostatic processes are in balance to maintain hemostasis, the use of ECMO in a critically ill child increases the risk of hemorrhagic or thromboembolic events due to a perturbation in the balance inherent of this complex system. The ECMO circuit has pro-hemostatic effects due to contact activation of hemostasis and inflammatory pathways. In addition, the critical illness of the child can cause dysregulation of hemostasis that may shift between hyper and hypocoagulable states over time.
Compared to in situ vascular physiology where pro and anti-hemostatic processes are in balance to maintain hemostasis, the use of ECMO in a critically ill child increases the risk of hemorrhagic or thromboembolic events due to a perturbation in the balance inherent of this complex system. The ECMO circuit has pro-hemostatic effects due to contact activation of hemostasis and inflammatory pathways. In addition, the critical illness of the child can cause dysregulation of hemostasis that may shift between hyper and hypocoagulable states over time.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Venous Thrombosis III: Interprofessional Care
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Venous Thrombosis IV: Nursing Management

